JP2015512439A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512439A5
JP2015512439A5 JP2015503938A JP2015503938A JP2015512439A5 JP 2015512439 A5 JP2015512439 A5 JP 2015512439A5 JP 2015503938 A JP2015503938 A JP 2015503938A JP 2015503938 A JP2015503938 A JP 2015503938A JP 2015512439 A5 JP2015512439 A5 JP 2015512439A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
derivative
pharmaceutically acceptable
acceptable salt
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015503938A
Other languages
English (en)
Japanese (ja)
Other versions
JP6188784B2 (ja
JP2015512439A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2013/050865 external-priority patent/WO2013150292A1/en
Publication of JP2015512439A publication Critical patent/JP2015512439A/ja
Publication of JP2015512439A5 publication Critical patent/JP2015512439A5/ja
Application granted granted Critical
Publication of JP6188784B2 publication Critical patent/JP6188784B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015503938A 2012-04-02 2013-04-02 炎症性および免疫性疾患の治療のための組成物 Expired - Fee Related JP6188784B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012901301A AU2012901301A0 (en) 2012-04-02 Treatment of inflammatory and immune disorders
AUAU2012901301 2012-04-02
PCT/GB2013/050865 WO2013150292A1 (en) 2012-04-02 2013-04-02 Composition for the treatment of inflammatory and immune disorders

Publications (3)

Publication Number Publication Date
JP2015512439A JP2015512439A (ja) 2015-04-27
JP2015512439A5 true JP2015512439A5 (enExample) 2016-04-07
JP6188784B2 JP6188784B2 (ja) 2017-08-30

Family

ID=48184233

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015503938A Expired - Fee Related JP6188784B2 (ja) 2012-04-02 2013-04-02 炎症性および免疫性疾患の治療のための組成物

Country Status (8)

Country Link
US (1) US9387218B2 (enExample)
EP (1) EP2836208B1 (enExample)
JP (1) JP6188784B2 (enExample)
CN (1) CN104427982B (enExample)
AU (1) AU2013203825B2 (enExample)
CA (1) CA2869243C (enExample)
MX (1) MX355103B (enExample)
WO (1) WO2013150292A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018051154A1 (en) * 2016-09-15 2018-03-22 Perscellmed Roth & Partner Compound of zinc salicylate and sulphur combination as a novel treatment for asthma and copd

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514421A (en) 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US20030069202A1 (en) * 2000-06-02 2003-04-10 Kern Kenneth Norman Compositions, kits, and methods for promoting defined health benefits
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
US6841173B2 (en) * 2002-03-26 2005-01-11 Peter L. Reynolds Compositions and methods directed towards sore muscles and joints
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
JP2005013124A (ja) * 2003-06-27 2005-01-20 Toyo Shinyaku:Kk 美容効果を有する食品組成物
US20050176807A1 (en) * 2004-02-09 2005-08-11 Friesen Kim G. Composition and method for use in cartilage affecting conditions
US20060029647A1 (en) 2004-02-09 2006-02-09 Friesen Kim G Composition and method for use in cartilage affecting conditions
US20070020218A1 (en) * 2005-07-21 2007-01-25 Eileen Richardson Composition and method for the treatment of psoriasis
US7335384B2 (en) * 2006-03-17 2008-02-26 4K Nutripharma International Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
EP2624821B1 (en) * 2010-10-07 2018-06-27 Eaglepharma Pty Ltd Combination therapy for the treatment of depression and other non-infectious diseases

Similar Documents

Publication Publication Date Title
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
JP2012180381A5 (enExample)
JP2014515373A5 (enExample)
JP2011173928A5 (enExample)
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP2010270124A5 (enExample)
NZ714963A (en) Compositions and methods for treating anemia
JP2015528491A5 (enExample)
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2015519329A5 (enExample)
RU2014141893A (ru) Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких
JP2013541583A5 (enExample)
JP2018513188A5 (enExample)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
MX377175B (es) Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc).
JP2015528501A5 (enExample)
JP2013518124A5 (enExample)
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
EP4578461A3 (en) Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2015516419A5 (enExample)
JP2016505050A5 (enExample)
JP2017061488A5 (enExample)
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.